视网膜脱离结局研究(REDOS):一项析因随机对照试验的研究方案
这是一项2×2析因、单盲随机对照试验,计划纳入约560例中等复杂度的原发性孔源性视网膜脱离(RRD)患者,比较玻璃体切除术(PPV)与PPV联合巩膜扣带(PPV-SB)、以及六氟化硫(SF6)与全氟丙烷(C3F8)气体填充的疗效。主要结局为单次手术解剖成功率(SSAS),随访至术后1年。该试验旨在为RRD手术决策提供更强证据。
要点
- 计划纳入约560例中等复杂度原发性RRD患者,1:1随机分组。
- 主要结局为单次手术解剖成功率(SSAS),随访至术后1年。
- 旨在检验补充巩膜扣带是否必要及C3F8是否必需。
核心结论
- 该试验将首次以2×2析因设计检验原发性RRD的修复技术,并首次随机比较两种最常用气体填充剂。
- 试验将回答补充巩膜扣带是否合理以及是否需要更长效的C3F8气体填充。
研究设计与样本
- 析因、单盲、随机对照试验,将中等复杂度原发性RRD患者按1:1随机分配至PPV或PPV-SB,并按1:1随机分配至SF6或C3F8气体填充。
- 计划招募约560例患者,以能够检测组间约10%的SSAS率差异。
- 术后采用多模态成像和生活质量问卷随访至术后1年。
主要发现
- 主要结局为单次手术解剖成功率(SSAS),定义为未因复发性RRD在手术室接受再次手术。
- 次要结局包括8-10周和6个月针孔视力(PHVA)、最终最佳矫正视力(BCVA)、最终视网膜状态(附着或脱离)、RRD复发时间、并发症严重程度和数量以及问卷结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few large randomized controlled trials provide strong evidence to guide surgical repair of primary rhegmatogenous retinal detachment (RRD) repair. The purpose of this factorial, single-blind, randomized controlled trial is to analyze and compare the surgical outcomes, functional visual outcomes, complications, and quality of life associated with RRD repair using (A) pars plana vitrectomy only (PPV) or PPV with scleral buckle (PPV-SB) and (B) sulfur hexafluoride gas (SF6) or perfluoropropane gas (C3F8) tamponade. METHODS: Eligible patients with moderately complex RRD will be randomized 1:1 to PPV or PPV-SB and 1:1 to SF6 or C3F8 gas tamponade. Approximately 560 patients will be recruited to be able to detect a difference of around 10% in SSAS rate between the groups. Patients will be followed using multimodal imaging and quality of life questionnaires after the surgical repair until 1 year postoperative. The primary outcome will be a single-surgery anatomic success (SSAS), defined as the absence of reoperation for recurrent RRD in the operating room. Secondary outcomes will be pinhole visual acuity (PHVA) at 8-10 weeks and 6 months, final best-corrected visual acuity (BCVA), final retina status (i.e., attached or detached), time to onset of RRD recurrence, severity and number of complications, and questionnaire results. DISCUSSION: This will be the first 2 × 2 factorial RCT examining repair techniques in primary RRD. It will also be the first RCT to compare gas tamponade between the two most common agents. Notably, it will be adequately powered to detect a clinically significant effect size. The use of multimodal imaging will also be a novel aspect of this study, allowing us to compare head-to-head the impact of adding an SB to the retina's recovery after RRD repair and of differing gas tamponades. Until now, the treatment of RRD has been largely guided by pragmatic retrospective cohort studies. There is a lack of strong evidence guiding therapeutic decisions and this trial will address (1) whether supplemental SB is justified and (2) whether longer duration gas tamponade with C3F8 is necessary. TRIAL REGISTRATION: ClinicalTrials.gov NCT05863312. Registered on 18 May 2023.
引用
- Hébert M, Bourgault S, Caissie M, et al. REtinal Detachment Outcomes Study (REDOS): study protocol for a factorial, randomized controlled trial. Trials. 2023. PMID: 38124155. doi:10.1186/s13063-023-07815-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。